TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 49 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Asset Management Company, LLC | 31,076,000 | $29,006,000 | 23.36% |
| INCOME RESEARCH & MANAGEMENT | 15,589,000 | $14,254,000 | 7.13% |
| SYMPHONY ASSET MANAGEMENT LLC | 17,600,000 | $16,378,000 | 5.14% |
| PenderFund Capital Management Ltd. | 8,470,000 | $11,097,000 | 3.46% |
| Radcliffe Capital Management, L.P. | 15,823,000 | $14,645,000 | 2.75% |
| LMR Partners LLP | 34,735,000 | $32,172,000 | 1.50% |
| Bracebridge Capital, LLC | 5,500,000 | $5,000,000 | 0.91% |
| Penn Capital Management Company, LLC | 5,079,000 | $4,701,000 | 0.78% |
| ONTARIO TEACHERS PENSION PLAN BOARD | 17,400,000 | $16,191,000 | 0.44% |
| WESTWOOD HOLDINGS GROUP INC | 29,605,000 | $27,715,000 | 0.42% |